Education
About Us
Working with TipRanks
Follow Us
Hologic (HOLX)
:HOLX
HOLX Analyst Ratings
Moderate Buy
6 Buy
7 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HOLX Stock 12 Month Forecast
Average Price Target
$73.33
▲(8.12% Upside)
| Highest Price Target$87.00 | Average Price Target$73.33 | Lowest Price Target$69.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$75
Buy
10.59%
Upside
Reiterated
08/01/25
Mizuho Securities
$70→$75
Buy
10.59%
Upside
Reiterated
07/31/25
Morgan Stanley
$65→$69
Hold
1.74%
Upside
Reiterated
07/31/25
Evercore ISI
$68→$69
Hold
1.74%
Upside
Reiterated
07/31/25
William Blair
―
Buy
―
Reiterated
07/31/25
Hologic's Growth Potential: Strong Q3 Results and Positive Outlook Justify Buy RatingWe come away from Hologic’s fiscal third-quarter update with continued confidence that the stock can outperform in the second half of 2025 and into calendar 2026, consistent with our view discussed earlier in July. The company’s quarterly results were above the high end of key guidance expectations and fiscal 2025 revenue guidance inched higher. Coupled with management commentary about visibility into demand trends in key segments, we take this update as a positive signal that the company can reaccelerate revenue and earnings growth. This is key for shares to move higher. Furthermore, we think management stating on this call that organic revenue growth should return to a midsingle-digit rate in 2026 and over the strategic plan horizon aligns with where investor thoughts were going into the call and bodes well for sentiment.
J.P. Morgan
$70→$80
Buy
17.96%
Upside
Reiterated
07/31/25
UBS
$65→$70
Hold
3.21%
Upside
Reiterated
07/31/25
BTIG
―
Hold
―
Reiterated
07/31/25
Needham
―
Hold
―
Reiterated
07/31/25
Leerink Partners
$70
Hold
3.21%
Upside
Reiterated
07/31/25
RBC Capital
$70→$72
Hold
6.16%
Upside
Reiterated
07/31/25
Bank of America Securities
$64→$70
Hold
3.21%
Upside
Reiterated
07/18/25
Stephens
$77→$70
Buy
3.21%
Upside
Reiterated
05/13/25
Jefferies
$78→$65
Hold
-4.16%
Downside
Reiterated
05/02/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$75
Buy
10.59%
Upside
Reiterated
08/01/25
Mizuho Securities
$70→$75
Buy
10.59%
Upside
Reiterated
07/31/25
Morgan Stanley
$65→$69
Hold
1.74%
Upside
Reiterated
07/31/25
Evercore ISI
$68→$69
Hold
1.74%
Upside
Reiterated
07/31/25
William Blair
―
Buy
―
Reiterated
07/31/25
Hologic's Growth Potential: Strong Q3 Results and Positive Outlook Justify Buy RatingWe come away from Hologic’s fiscal third-quarter update with continued confidence that the stock can outperform in the second half of 2025 and into calendar 2026, consistent with our view discussed earlier in July. The company’s quarterly results were above the high end of key guidance expectations and fiscal 2025 revenue guidance inched higher. Coupled with management commentary about visibility into demand trends in key segments, we take this update as a positive signal that the company can reaccelerate revenue and earnings growth. This is key for shares to move higher. Furthermore, we think management stating on this call that organic revenue growth should return to a midsingle-digit rate in 2026 and over the strategic plan horizon aligns with where investor thoughts were going into the call and bodes well for sentiment.
J.P. Morgan
$70→$80
Buy
17.96%
Upside
Reiterated
07/31/25
UBS
$65→$70
Hold
3.21%
Upside
Reiterated
07/31/25
BTIG
―
Hold
―
Reiterated
07/31/25
Needham
―
Hold
―
Reiterated
07/31/25
Leerink Partners
$70
Hold
3.21%
Upside
Reiterated
07/31/25
RBC Capital
$70→$72
Hold
6.16%
Upside
Reiterated
07/31/25
Bank of America Securities
$64→$70
Hold
3.21%
Upside
Reiterated
07/18/25
Stephens
$77→$70
Buy
3.21%
Upside
Reiterated
05/13/25
Jefferies
$78→$65
Hold
-4.16%
Downside
Reiterated
05/02/25
Best Analysts Covering Hologic
1 Month
xxx
Success Rate
10/21 ratings generated profit
Average Return
+1.20%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 47.62% of your transactions generating a profit, with an average return of +1.20% per trade.
3 Months
xxx
Success Rate
9/21 ratings generated profit
Average Return
+1.17%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +1.17% per trade.
1 Year
Success Rate
7/11 ratings generated profit
Average Return
+5.61%
reiterated a buy rating 3 months ago
Copying Andrew Cooper's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +5.61% per trade.
2 Years
xxx
Success Rate
4/11 ratings generated profit
Average Return
-3.40%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 36.36% of your transactions generating a profit, with an average return of -3.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HOLX Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
4
7
7
12
7
Hold
11
15
14
22
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
22
21
34
20
Each month's total comprises the sum of three months' worth of ratings.
HOLX Financial Forecast
HOLX Stock Forecast FAQ
What is HOLX’s average 12-month price target, according to analysts?
Based on analyst ratings, Hologic’s 12-month average price target is 73.33.
What is HOLX’s upside potential, based on the analysts’ average price target?
Hologic has 8.12% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HOLX a Buy, Sell or Hold?
Hologic has a consensus rating of Moderate Buy which is based on 6 buy ratings, 7 hold ratings and 0 sell ratings.
What is Hologic’s price target?
The average price target for Hologic is 73.33. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $87.00 ,the lowest forecast is $69.00. The average price target represents 8.12% Increase from the current price of $67.82.
The highest analyst price target is $87.00 ,the lowest forecast is $69.00. The average price target represents 8.12% Increase from the current price of $67.82.
What do analysts say about Hologic?
Hologic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of HOLX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.